MedTrace Logo

Heart Rate Control With Esmolol in Septic Shock

NCT01231698 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2013-01-24

No results posted yet for this study

Summary

The purpose of this study is investigate the effects on systemic hemodynamics and organ function of esmolol when used to maintain heart rate below a predefined threshold in patients with septic shock.

Conditions

  • Septic Shock

Interventions

DRUG

esmolol

Strict heart rate control: esmolol at any dose to maintain heart rate between 95 and 80 bpm.

OTHER

control

standard treatment without strict heart rate control

Sponsors & Collaborators

  • Andrea Morelli

    lead OTHER

Principal Investigators

  • Andrea Morelli, MD · University of Roma La Sapienza

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01231698 on ClinicalTrials.gov